Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024 2025
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Inaugural lecture celebrates Qwaqwa founder, Morena Mopeli Mokhachane
2014-09-12

 

Photo: RooistoelTV

Every historical era presents its own challenges and creates its own leaders who take up the call to address those challenges.

This was expressed by Dr Nyefolo Malete who presented the Inaugural Memorial Lecture on 6 September 2014 at the Qwaqwa Campus. The lecture honoured the live of the Qwaqwa founder, Morena Paulus Mopeli Mokhachane.

Dr Malete said that Morena Mopeli played his part in history as a skilled negotiator, formidable team player and a liberator who held good human relations in high regard.

“Morena Mopeli lived at the time when Southern Africa was experiencing a moment of frustration and despair. It was faced with conflicts, battles, starvation and turmoil in preparation for a transformation that was to serve as the mirror of the political and social stage which existed until 1994,” Dr Malete said.

“He was a hopeful leader and thinker who played a critical role in assisting his brother Moshoeshoe to build and protect Lesotho where it was humanly possible. He participated in most of the negotiations with all the groups to create peace and protect the borders of Lesotho. He was a good, intelligent and formidable diplomat who was aware of his role as a leader. He was aware that he could influence the future through dialogue.”

Dr Malete said that Africa needs leaders like Mopeli. Leaders who can expand the capacity to remain open to possibilities and “envision a positive future in the face of uncertainty and to creatively construct pathways that can be embraced by all people who collectively seek to turn possibilities into reality.”

In attendance at the lecture were dignitaries from the Lesotho Royal House, the Free State Provincial Government and the Free State House of Traditional Leaders. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept